YusufYaziciMD

Rheumatology • New York, NY

Assistant Professor, Medicine, New York University School of Medicine

Join to view full profile

Dr. Yazici is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Yazici's full profile

Already have an account?

Office
333 E 38th St
# Nyu
New York, NY 10016
Phone+1 646-501-7400

Fax+1 646-501-7228

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 1997 - 2000
Creighton University School of Medicine (Omaha)Residency, Internal Medicine, 1994 - 1997
Istanbul University FomClass of 1994

Certifications & Licensure

NY State Medical License 1997 - 2025
American Board of Internal Medicine Rheumatology

Publications & Presentations

PubMed

85 citations
The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models
Betty Tam, Kevin Chiu, Heekyung Chung, Carine Bossard, John Duc Nguyen
Cancer Letters. 2020-03-31
53 citations
A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitativ...
Theodore Pincus, Yusuf Yazici, Martin J. Bergman, Ross Maclean, Timothy Harrington
Best Practice & Research. Clinical Rheumatology. 2007-08-01
92 citations
A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study
Yusuf Yazici, Timothy E. McAlindon, Roy Fleischmann, Allan Gibofsky, Nancy E Lane
Osteoarthritis and Cartilage. 2017-10-01

Press Mentions

What Rheumatologists Need to Know About the Management of Rare Diseases in RheumatologyMarch 3rd, 2023
Biosplice Announces Data from Recent Clinical Trials in Knee Osteoarthritis and the Initiation of a New Phase 3 TrialNovember 11th, 2022
“She Is Such a Puzzle”: Colorado Teen’s Months-Long Ordeal Spotlights Mysteries of Long COVIDOctober 1st, 2021
Join now to see all

Other Languages

Turkish